423 related articles for article (PubMed ID: 25934888)
1. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
[TBL] [Abstract][Full Text] [Related]
2. EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency.
Fu W; Lei C; Yu Y; Liu S; Li T; Lin F; Fan X; Shen Y; Ding M; Tang Y; Ye X; Yang Y; Hu S
Clin Cancer Res; 2019 May; 25(9):2835-2847. PubMed ID: 30670492
[TBL] [Abstract][Full Text] [Related]
3. A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors.
Smith DC; Chugh R; Patnaik A; Papadopoulos KP; Wang M; Kapoun AM; Xu L; Dupont J; Stagg RJ; Tolcher A
Invest New Drugs; 2019 Aug; 37(4):722-730. PubMed ID: 30591982
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency.
Hu S; Fu W; Li T; Yuan Q; Wang F; Lv G; Lv Y; Fan X; Shen Y; Lin F; Tang Y; Ye X; Yang Y; Lei C
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275151
[TBL] [Abstract][Full Text] [Related]
5. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
[TBL] [Abstract][Full Text] [Related]
6. Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells.
Yen WC; Fischer MM; Hynes M; Wu J; Kim E; Beviglia L; Yeung VP; Song X; Kapoun AM; Lewicki J; Gurney A; Simeone DM; Hoey T
Clin Cancer Res; 2012 Oct; 18(19):5374-86. PubMed ID: 22952347
[TBL] [Abstract][Full Text] [Related]
7. Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
Hubmann R; Schnabl S; Araghi M; Schmidl C; Rendeiro AF; Hilgarth M; Demirtas D; Ali F; Staber PB; Valent P; Zielinski C; Jäger U; Shehata M
Cells; 2020 Jun; 9(6):. PubMed ID: 32570839
[TBL] [Abstract][Full Text] [Related]
8. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
9. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
10. The role of Notch receptor expression in bile duct development and disease.
Flynn DM; Nijjar S; Hubscher SG; de Goyet Jde V; Kelly DA; Strain AJ; Crosby HA
J Pathol; 2004 Sep; 204(1):55-64. PubMed ID: 15307138
[TBL] [Abstract][Full Text] [Related]
11. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis.
Ruan ZB; Fu XL; Li W; Ye J; Wang RZ; Zhu L
Biomed Pharmacother; 2016 Dec; 84():666-673. PubMed ID: 27697639
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Notch1, 2, 3 genes silencing on Notch and nuclear factor-κB signaling pathway of macrophages derived from patients with coronary artery disease].
Ruan ZB; Fu XL; Li W; Ye J; Wang RZ; Yin YG; Zhu L
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):786-792. PubMed ID: 27667278
[No Abstract] [Full Text] [Related]
13. Notch2 and Notch3 function together to regulate vascular smooth muscle development.
Wang Q; Zhao N; Kennard S; Lilly B
PLoS One; 2012; 7(5):e37365. PubMed ID: 22615991
[TBL] [Abstract][Full Text] [Related]
14. Loss of Notch2 and Notch3 in vascular smooth muscle causes patent ductus arteriosus.
Baeten JT; Jackson AR; McHugh KM; Lilly B
Genesis; 2015 Dec; 53(12):738-48. PubMed ID: 26453897
[TBL] [Abstract][Full Text] [Related]
15. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
Wang K; Zhang Q; Li D; Ching K; Zhang C; Zheng X; Ozeck M; Shi S; Li X; Wang H; Rejto P; Christensen J; Olson P
Clin Cancer Res; 2015 Mar; 21(6):1487-96. PubMed ID: 25564152
[TBL] [Abstract][Full Text] [Related]
16. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
[TBL] [Abstract][Full Text] [Related]
17. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.
Hoey T; Yen WC; Axelrod F; Basi J; Donigian L; Dylla S; Fitch-Bruhns M; Lazetic S; Park IK; Sato A; Satyal S; Wang X; Clarke MF; Lewicki J; Gurney A
Cell Stem Cell; 2009 Aug; 5(2):168-77. PubMed ID: 19664991
[TBL] [Abstract][Full Text] [Related]
18. Differential Regulation of NOTCH2 and NOTCH3 Contribute to Their Unique Functions in Vascular Smooth Muscle Cells.
Baeten JT; Lilly B
J Biol Chem; 2015 Jun; 290(26):16226-37. PubMed ID: 25957400
[TBL] [Abstract][Full Text] [Related]
19. Effects of Notch2 and Notch3 on Cell Proliferation and Apoptosis of Trophoblast Cell Lines.
Zhao WX; Zhuang X; Huang TT; Feng R; Lin JH
Int J Med Sci; 2015; 12(11):867-74. PubMed ID: 26640406
[TBL] [Abstract][Full Text] [Related]
20. NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.
Pastò A; Serafin V; Pilotto G; Lago C; Bellio C; Trusolino L; Bertotti A; Hoey T; Plateroti M; Esposito G; Pinazza M; Agostini M; Nitti D; Amadori A; Indraccolo S
Cancer Res; 2014 Apr; 74(7):2106-18. PubMed ID: 24525742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
